LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 5.36 | 27.76 | 1 | 320 | 0.0031 | -0.6101 | MN20160318_Q01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 5.36 | 27.76 | 793 | 320 | 2.4754 | 1.5857 | MN20160318_Q01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 5.36 | 27.76 | 3 | 320 | 0.0094 | -0.4677 | MN20160318_Q01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 5.36 | 27.76 | 705 | 320 | 2.2007 | 1.5010 | MN20160318_Q01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 7.06 | 27.76 | 2 | 360 | 0.0056 | -0.5091 | MN20160318_Q01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 7.06 | 27.76 | 893 | 360 | 2.4806 | 1.5571 | MN20160318_Q01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 7.06 | 27.76 | 7 | 360 | 0.0194 | -0.3111 | MN20160318_Q01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 7.06 | 27.76 | 774 | 360 | 2.1500 | 1.4601 | MN20160318_Q01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 8.76 | 27.76 | 3 | 401 | 0.0075 | -0.4387 | MN20160318_Q01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 8.76 | 27.76 | 1012 | 401 | 2.5228 | 1.5429 | MN20160318_Q01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 8.76 | 27.76 | 15 | 401 | 0.0374 | -0.1476 | MN20160318_Q01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 8.76 | 27.76 | 926 | 401 | 2.3084 | 1.4850 | MN20160318_Q01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 10.46 | 27.76 | 5 | 438 | 0.0114 | -0.3498 | MN20160318_Q01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 10.46 | 27.76 | 1045 | 438 | 2.3823 | 1.4872 | MN20160318_Q01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 10.46 | 27.76 | 22 | 438 | 0.0502 | -0.0567 | MN20160318_Q01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 10.46 | 27.76 | 908 | 438 | 2.0700 | 1.4009 | MN20160318_Q01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 12.17 | 27.76 | 5 | 489 | 0.0102 | -0.3391 | MN20160318_Q01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 12.17 | 27.76 | 1124 | 489 | 2.2982 | 1.4454 | MN20160318_Q01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 12.17 | 27.76 | 33 | 489 | 0.0675 | 0.0427 | MN20160318_Q01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 12.17 | 27.76 | 1084 | 489 | 2.2164 | 1.4240 | MN20160318_Q01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 13.87 | 27.76 | 13 | 604 | 0.0215 | -0.1569 | MN20160318_Q01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 13.87 | 27.76 | 1216 | 604 | 2.0109 | 1.3403 | MN20160318_Q01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 13.87 | 27.76 | 45 | 604 | 0.0744 | 0.1148 | MN20160318_Q01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 13.87 | 27.76 | 1133 | 604 | 1.8736 | 1.3034 | MN20160318_Q01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 15.58 | 27.76 | 24 | 685 | 0.0350 | -0.0310 | MN20160318_Q01 | L18 |